HU171945B - Process for preparing p-biphenylyl-esters of 16-phenyl-11,15-tetrahydro-pyranyloxy-omega-tetranor-prostaglandin - Google Patents

Process for preparing p-biphenylyl-esters of 16-phenyl-11,15-tetrahydro-pyranyloxy-omega-tetranor-prostaglandin

Info

Publication number
HU171945B
HU171945B HU73PI00000453A HUPI000453A HU171945B HU 171945 B HU171945 B HU 171945B HU 73PI00000453 A HU73PI00000453 A HU 73PI00000453A HU PI000453 A HUPI000453 A HU PI000453A HU 171945 B HU171945 B HU 171945B
Authority
HU
Hungary
Prior art keywords
pyranyloxy
tetranor
biphenylyl
prostaglandin
omega
Prior art date
Application number
HU73PI00000453A
Other languages
Hungarian (hu)
Inventor
Michael R Johnson
Thomas K Schaaf
Jasjit S Bindra
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of HU171945B publication Critical patent/HU171945B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/54Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5407Acyclic saturated phosphonium compounds
HU73PI00000453A 1972-11-08 1973-11-08 Process for preparing p-biphenylyl-esters of 16-phenyl-11,15-tetrahydro-pyranyloxy-omega-tetranor-prostaglandin HU171945B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30481572A 1972-11-08 1972-11-08

Publications (1)

Publication Number Publication Date
HU171945B true HU171945B (en) 1978-04-28

Family

ID=23178143

Family Applications (2)

Application Number Title Priority Date Filing Date
HU73PI00000453A HU171945B (en) 1972-11-08 1973-11-08 Process for preparing p-biphenylyl-esters of 16-phenyl-11,15-tetrahydro-pyranyloxy-omega-tetranor-prostaglandin
HU73PI00000400A HU171818B (en) 1972-11-08 1973-11-08 Process for preparing omega-aryl- and oxa-prostaglandin-p-diphenyl-ester derivatives

Family Applications After (1)

Application Number Title Priority Date Filing Date
HU73PI00000400A HU171818B (en) 1972-11-08 1973-11-08 Process for preparing omega-aryl- and oxa-prostaglandin-p-diphenyl-ester derivatives

Country Status (24)

Country Link
JP (1) JPS5644068B2 (en)
AR (2) AR204816A1 (en)
AT (1) AT347607B (en)
BE (1) BE807047A (en)
CA (1) CA1027559A (en)
CH (1) CH601222A5 (en)
CS (1) CS188175B2 (en)
DD (2) DD111370A5 (en)
DE (2) DE2355042A1 (en)
ES (2) ES420326A1 (en)
FI (1) FI58116C (en)
FR (2) FR2205339B1 (en)
GB (1) GB1456511A (en)
HU (2) HU171945B (en)
IE (1) IE39686B1 (en)
IL (1) IL43553A (en)
IN (1) IN139905B (en)
NL (1) NL7315240A (en)
NO (2) NO145437C (en)
PH (2) PH15504A (en)
SE (2) SE420198B (en)
SU (2) SU538659A3 (en)
YU (2) YU287973A (en)
ZA (1) ZA738593B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2361381A1 (en) * 1972-07-13 1978-03-10 Pfizer (15)-(Hetero) aryl prostaglandin analogues - with long-lasting prostaglandin-like activity
US3929862A (en) * 1974-01-08 1975-12-30 Upjohn Co Substituted tolylesters of PGF{HD 2{B {60
US3998869A (en) * 1974-11-14 1976-12-21 The Upjohn Company Substituted anilide esters of 16-substituted PGE2
DE2737807A1 (en) * 1976-08-27 1978-03-09 Pfizer C LOW 1 -P-BIPHENYLESTER OF OMEGA-PENTANORPROSTAGLANDINES
US6531504B2 (en) * 2001-05-17 2003-03-11 Allergan, Inc. Prostanoic acid derivatives as agents for lowering intraocular pressure

Also Published As

Publication number Publication date
IL43553A (en) 1979-10-31
NO146280B (en) 1982-05-24
GB1456511A (en) 1976-11-24
DD113211A5 (en) 1975-05-20
AR204816A1 (en) 1976-03-05
YU287973A (en) 1982-02-25
DE2365999A1 (en) 1977-05-12
ATA937173A (en) 1978-05-15
FR2275452A1 (en) 1976-01-16
BE807047A (en) 1974-05-08
IE39686L (en) 1974-05-08
FI58116C (en) 1980-12-10
NO145437C (en) 1982-03-24
AR202311A1 (en) 1975-05-30
ES434687A1 (en) 1976-12-16
ZA738593B (en) 1974-10-30
SU1021340A3 (en) 1983-05-30
IN139905B (en) 1976-08-14
JPS5644068B2 (en) 1981-10-16
FR2205339B1 (en) 1980-01-04
YU264480A (en) 1983-04-27
NL7315240A (en) 1974-05-10
IE39686B1 (en) 1978-12-06
FR2205339A1 (en) 1974-05-31
DE2355042A1 (en) 1974-05-22
PH13794A (en) 1980-10-01
SU538659A3 (en) 1976-12-05
JPS49100060A (en) 1974-09-20
ES420326A1 (en) 1976-03-16
CS188175B2 (en) 1979-02-28
FR2275452B1 (en) 1977-12-16
AT347607B (en) 1979-01-10
NO146280C (en) 1982-09-01
DD111370A5 (en) 1975-02-12
SE7704369L (en) 1977-04-15
AU6222573A (en) 1975-05-08
PH15504A (en) 1983-02-03
NO743588L (en) 1974-05-09
NO145437B (en) 1981-12-14
CA1027559A (en) 1978-03-07
CH601222A5 (en) 1978-06-30
IL43553A0 (en) 1974-03-14
SE420198B (en) 1981-09-21
FI58116B (en) 1980-08-29
HU171818B (en) 1978-03-28

Similar Documents

Publication Publication Date Title
JPS5387333A (en) Process for preparing acyldiamine
CS183689B2 (en) Process for preparing pyridylphenoxyalkane derivatives
CS185216B2 (en) Process for preparing dimethylethere
YU34892B (en) Process for preparing novel benzoyl-benzofuran derivatives
HU175725B (en) Process for preparing tetrachloro-isophtalonitrile
HU171156B (en) Process for preparing omega-aryl-nor-prostaglandins
YU35583B (en) Process for preparing 1-hydroxy-2-pyridones
KR780000072B1 (en) Process for preparing new 2-alkylamino-dihydropyridines
YU36015B (en) Process for preparing 1-ethyl-imidazoles
IL43385A0 (en) Process for preparing perchloro-methylmercaptane
YU238572A (en) Process for preparing n-(-ethyl-delta-pyrrolidyl-methyl)-2-methoxy-5-sulfamidobenzamide
HU171945B (en) Process for preparing p-biphenylyl-esters of 16-phenyl-11,15-tetrahydro-pyranyloxy-omega-tetranor-prostaglandin
YU88173A (en) New process for preparing tatracyclic compounds
KR780000029B1 (en) Process for preparing novel benzyl-pyrimidines
YU36303B (en) Process for preparing tetramisol
YU82473A (en) Process for preparing novel phenyl-formamides
YU39295B (en) Process for preparing substituted chloroacetylanilides
CH610900A5 (en) Process for preparing novelaminopyrazoloisoquinoline derivatives
YU109380A (en) Process for preparing m-dioxane-5-methylamine
CH613977A5 (en) Process for preparing tricyclohexyl-tin derivatives
IE38660B1 (en) Process for preparing ketones
YU212873A (en) Process for preparing bicyclomycin
JPS53149944A (en) Process for preparing 22aminoobenzylamine
ZA73721B (en) Process for preparing polythiodiglycol
YU35253B (en) Process for preparing 2-imidazolidione derivatives